Clinical Licensing Opportunity EveristHealth’s CE-marked AngioDefender rapid cardiovascular risk test, combined with the Vascular Age Calculator and COVIDAge Risk Calculator, creates a compelling B2B licensing proposition for clinics, hospitals, and specialty care centers seeking quick risk stratification. Opportunities include licensing the platform, offering a subscription model to health systems, and integrating the tools into clinical workflows and patient portals or EMR/EHR systems.

Employer Partnerships The dual focus on heart health and COVID complication risk opens doors to corporate wellness programs and insurers. Consider white-labeling the COVIDAge and AngioDefender tools within employer health portals or preventive care programs, and partnering with insurers or benefits administrators to include risk-based onboarding and personalized coaching.

Competitive Differentiation EveristHealth combines a fast, easy-to-understand cardiovascular assessment with a COVID risk calculator and a validated test, offering a differentiated value proposition for patient risk awareness and motivation to change behavior. Use these differentiators in outreach to clinics, telehealth platforms, and digital health ecosystems that require rapid, clinician-friendly risk screening.

Growth & Partnerships With a small team and external funding, scaling will benefit from channel partnerships with healthcare device distributors, health IT vendors, and telemedicine platforms. Target mid-market clinics and health systems expanding preventive care, and pursue co-marketing and integration-led deals to accelerate adoption.

Tech Enablement A cloud-first stack and modern web technologies position EveristHealth to offer API access or developer-friendly integrations with EMR/EHR systems, patient portals, and telehealth solutions. Present a clear data integration and integration story to IT buyers and value-based care teams.